Baird Reiterates Neutral Rating on HCA Healthcare, Inc. (HCA)

Market Context

HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $389.62 with a market capitalization of $117.1B. The stock has declined 19.1% over the past 52 weeks.

Analyst coverage from Baird provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for HCA Healthcare, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for HCA Healthcare, Inc.

Among the 10 most recent ratings: 6 Buy, 3 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 27, 2026	Morgan Stanley	Underweight	N/A
Jul 27, 2026	UBS	Buy	N/A
Jul 27, 2026	RBC Capital	Outperform	N/A
Jul 27, 2026	Oppenheimer	Outperform	N/A
Jul 27, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View HCA Stock Page